|
|
|
|
LEADER |
00000cam a2200000Mi 4500 |
001 |
EBOOKCENTRAL_ocn476073182 |
003 |
OCoLC |
005 |
20240329122006.0 |
006 |
m o d |
007 |
cr mn|---||||| |
008 |
091207s2007 vtu ob 001 0 eng d |
040 |
|
|
|a EBLCP
|b eng
|e pn
|c EBLCP
|d NRU
|d OCLCQ
|d IDEBK
|d OCLCQ
|d UKDOC
|d OCLCQ
|d COCUF
|d OCLCO
|d AGLDB
|d OCLCF
|d ZCU
|d OCLCQ
|d MERUC
|d OCLCQ
|d OCLCO
|d U3W
|d OCLCQ
|d ICG
|d OCLCQ
|d DKC
|d AU@
|d OCLCQ
|d UX1
|d OL$
|d OCLCQ
|d ADU
|d OCLCO
|d OCLCQ
|d OCLCA
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCL
|
019 |
|
|
|a 814452284
|
020 |
|
|
|a 9780080521855
|q (electronic bk.)
|
020 |
|
|
|a 0080521851
|q (electronic bk.)
|
020 |
|
|
|a 1281020451
|
020 |
|
|
|a 9781281020451
|
020 |
|
|
|z 9780123725516
|q (alk. paper)
|
029 |
1 |
|
|a DEBBG
|b BV044124901
|
035 |
|
|
|a (OCoLC)476073182
|z (OCoLC)814452284
|
050 |
|
4 |
|a RC271.I45C363 2007
|a RC271.I45 C363 2007eb
|
060 |
|
4 |
|a QZ 266
|b C2146 2007
|
072 |
|
7 |
|a K
|2 bicssc
|
082 |
0 |
4 |
|a 616.99/4061
|
049 |
|
|
|a UAMI
|
100 |
1 |
|
|a Prendergast, George C.
|
245 |
1 |
0 |
|a Cancer Immunotherapy :
|b Immune Suppression and Tumor Growth.
|
260 |
|
|
|a Burlington :
|b Elsevier,
|c 2007.
|
300 |
|
|
|a 1 online resource (429 pages)
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
520 |
|
|
|a There has been major growth in understanding immune suppression mechanisms and its relationship to cancer progression and therapy. This book highlights emerging new principles of immune suppression that drive cancer and it offers radically new ideas about how therapy can be improved by attacking these principles. Following work that firmly establishes immune escape as an essential trait of cancer, recent studies have now defined specific mechanisms of tumoral immune suppression. It also demonstrates how attacking tumors with molecular targeted therapeutics or traditional chemotherapeutic drugs.
|
505 |
0 |
|
|a Front cover; Cancer Immunotherapy: Immune Suppression and Tumor Growth; Copyright page; Table of contents; Contributors; PART I: PRINCIPLES OF CANCER IMMUNOBIOLOGY; CHAPTER 1: Introduction; CHAPTER 2: Cancer Immunoediting: From Immune Surveillance to Immune Escape; CHAPTER 3: Immunosurveillance: Innate and Adaptive Antitumor Immunity; CHAPTER 4: Cytokine Regulation of Immune Tolerance to Tumors; CHAPTER 5: Immunological Sculpting: Natural Killer Cell Receptors and Ligands; CHAPTER 6: Immune Escape: Immunosuppressive Networks; PART II: CANCER THERAPEUTICS.
|
588 |
0 |
|
|a Print version record.
|
504 |
|
|
|a Includes bibliographical references and index.
|
590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
650 |
|
0 |
|a Cancer
|x Immunotherapy.
|
650 |
|
0 |
|a Antineoplastic agents
|x Therapeutic use.
|
650 |
|
0 |
|a Tumors
|x Immunological aspects.
|
650 |
1 |
2 |
|a Neoplasms
|x therapy
|
650 |
2 |
2 |
|a Antineoplastic Agents
|x therapeutic use
|
650 |
2 |
2 |
|a Immunotherapy
|x methods
|
650 |
|
6 |
|a Cancer
|x Immunothérapie.
|
650 |
|
6 |
|a Anticancéreux
|x Emploi en thérapeutique.
|
650 |
|
6 |
|a Tumeurs
|x Immunologie.
|
650 |
|
7 |
|a Antineoplastic agents
|x Therapeutic use
|2 fast
|
650 |
|
7 |
|a Cancer
|x Immunotherapy
|2 fast
|
650 |
|
7 |
|a Tumors
|x Immunological aspects
|2 fast
|
700 |
1 |
|
|a Jaffee, Elizabeth M.
|
758 |
|
|
|i has work:
|a Cancer immunotherapy (Text)
|1 https://id.oclc.org/worldcat/entity/E39PCFBGvKtrvWQJkKxvkb9yQy
|4 https://id.oclc.org/worldcat/ontology/hasWork
|
776 |
1 |
|
|z 9780123725516
|
856 |
4 |
0 |
|u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=298272
|z Texto completo
|
938 |
|
|
|a 123Library
|b 123L
|n 42888
|
938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL298272
|
938 |
|
|
|a ProQuest MyiLibrary Digital eBook Collection
|b IDEB
|n 102045
|
994 |
|
|
|a 92
|b IZTAP
|